21h
Investor's Business Daily on MSNDoes AstraZeneca Have 'One Pill To Rule Them All' In Cholesterol?AstraZeneca said Monday its experimental pill lowered "bad" LDL cholesterol by 51%. The results showed promise again rival drugs from Merck and NewAmsterdam Pharma, but AstraZeneca stock fell in line ...
AstraZeneca Plc’s experimental cholesterol drug significantly reduced “bad” cholesterol in a mid-stage trial, boosting hopes ...
AstraZeneca Plc’s experimental cholesterol drug significantly reduced “bad” cholesterol in a mid-stage trial, boosting hopes ...
8don MSN
The largest analysis to examine the best way to lower levels of "bad" cholesterol in patients with blocked arteries shows ...
Statins are very cheap and highly effective cholesterol-lowering drugs -- but high-risk heart patients may have an even better option, a new evidence review says. Combining statins with another ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results